MEDICIS PHARMACEUTICAL CORP Files SEC form 8-K, Entry into a Material Definitive Agreement (EDGAR...

| Request a Trial to NEW EDGAR Online Pro Form 8-K for MEDICIS PHARMACEUTICAL CORP Entry into a Material Definitive Agreement Item 1.01. Entry into a Material Definitive Agreement. On June 16, 2008, Medicis Pharmaceutical Corporation ("Medicis") entered into a definitive merger agreement (the "Merger Agreement") with LipoSonix, Inc., a privately held Delaware corporation ("LipoSonix"). Summary of the terms of the Merger Agreement: Form of Transaction. Donatello, Inc. ("Merger Sub"), a newly formed wholly-owned subsidiary of Medicis, will merge with and into LipoSonix (the "Merger"), with LipoSonix remaining as the surviving corporation and a wholly-owned subsidiary of Medicis. Merger Consideration. All outstanding shares of LipoSonix's common stock and preferred stock, as well as all vested options, will be converted into the... [read full story]